Feigin V. L., Roth G. A., Naghavi M. et al., The Lancet Neurology 2016 Vol. 15 No. 9 P. 913-924
Background
The contribution of modifiable risk factors to the increasing global and regional burden of stroke is unclear, but knowledge about this contribution is crucial for informing stroke prevention strategies. We used data from the Global Burden of Disease Study 2013 (GBD 2013) to estimate the population-attributable fraction (PAF) of stroke-related disability-adjusted life-years (DALYs) associated with ...
Added: June 10, 2016
Vlassov V., JAMA Pediatrics 2016 Vol. 170 No. 3 P. 267-287
Importance The literature focuses on mortality among children younger than 5 years. Comparable information on nonfatal health outcomes among these children and the fatal and nonfatal burden of diseases and injuries among older children and adolescents is scarce.
Objective To determine levels and trends in the fatal and nonfatal burden of diseases and injuries among younger ...
Added: December 22, 2015
Vlassov V., The Lancet 2016 Vol. 388 No. 10053 P. 1545-1602
Background
Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 ...
Added: October 13, 2016
Vlassov V., New England Journal of Medicine 2017 Vol. 377 No. 1 P. 13-27
BACKGROUND:
Although the rising pandemic of obesity has received major attention in many countries, the effects of this attention on trends and the disease burden of obesity remain uncertain.
METHODS:
We analyzed data from 68.5 million persons to assess the trends in the prevalence of overweight and obesity among children and adults between 1980 and 2015. Using the ...
Added: July 9, 2017
Vlassov V., The Lancet 2017 Vol. 389 No. 10082 P. 1885-1906
The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers ...
Added: April 9, 2017
Vlassov V., Vishnevsky A. G., The Lancet Public Health 2017 Vol. 2 No. 5 P. e207-e208
In studies of massive changes in social life, researchers often have to rely on low-quality retrospective data such as memoirs and manipulated government reports as opposed to reliable data such as vital registration. The dissolution of the Soviet Union in 1991 was an unpredictable event with large-scale consequences for the lives of millions of Russians. ...
Added: April 13, 2017
Ferreira M., de Luca K., Haile L. M. et al., The Lancet Rheumatology 2023 Vol. 5 No. 6 P. e316-e329
Background
Low back pain is highly prevalent and the main cause of years lived with disability (YLDs). We present the most up-to-date global, regional, and national data on prevalence and YLDs for low back pain from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021.
Methods
Population-based studies from 1980 to 2019 identified in a systematic ...
Added: July 25, 2023
Vlassov V., The Lancet Neurology 2024 P. 1-10
Background
Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, ...
Added: March 16, 2024
Vlassov V., Neuro-epidemiology 2015 Vol. 45 No. 3 P. 161-176
Background: Global stroke epidemiology is changing rapidly. Although age-standardized rates of stroke mortality have decreased worldwide in the past 2 decades, the absolute numbers of people who have a stroke every year, and live with the consequences of stroke or die from their stroke, are increasing. Regular updates on the current level of stroke burden ...
Added: October 29, 2015
Vlassov V.V., The Lancet 2016 Vol. 388 No. 10049 P. 1081-1088
Background
With recent improvements in vaccines and treatments against viral hepatitis, an improved understanding of the burden of viral hepatitis is needed to inform global intervention strategies. We used data from the Global Burden of Disease (GBD) Study to estimate morbidity and mortality for acute viral hepatitis, and for cirrhosis and liver cancer caused by viral ...
Added: July 9, 2016
Vlassov V., The Lancet 2017 Vol. 390 No. 10091 P. 231-266
Background
National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we ...
Added: May 28, 2017
Vlassov V., The Lancet Infectious Diseases 2018 Vol. 18 No. 3 P. 261-284
Background An understanding of the trends in tuberculosis incidence, prevalence, and mortality is crucial to tracking
of the success of tuberculosis control programmes and identification of remaining challenges. We assessed trends in
the fatal and non-fatal burden of tuberculosis over the past 25 years for 195 countries and territories.
Methods We analysed 10 691 site-years of vital registration ...
Added: December 5, 2017
Vlassov V., The Lancet 2015 Vol. 386 No. 10009 P. 2145-2191
Background
The global burden of diseases, injuries and risk factors 2013 study (GBD 2013) seeks to synthesize all
available epidemiological data using a coherent measurement framework, standardized estimation
methods, and transparent data sources to facilitate comparisons of health loss across causes, age‐sex
groups, and geographies and over time. The GBD can be used to generate summary measures such ...
Added: August 21, 2015
Haagsma J., James S., Castle C. et al., Injury Prevention 2020 Vol. 26 No. Supp 1 P. i12-i26
Background The epidemiological transition of non-communicable diseases replacing infectious diseases as the main contributors to disease burden has been well documented in global health literature. Less focus, however, has been given to the relationship between sociodemographic changes and injury. The aim of this study was to examine the association between disability-adjusted life years (DALYs) from ...
Added: February 26, 2020
Vlassov V., Neuro-epidemiology 2015 Vol. 45 No. 3 P. 190-202
Background: Recent evidence suggests that stroke is increasing as a cause of morbidity and mortality in younger adults, where it carries particular significance for working individuals. Accurate and up-to-date estimates of stroke burden are important for planning stroke prevention and management in younger adults. Objectives: This study aims to estimate prevalence, mortality and disability-adjusted life ...
Added: October 29, 2015
Vlassov V., The Lancet 2018 Vol. 392 No. 10152 P. 1015-1035
Background
Alcohol use is a leading risk factor for death and disability, but its overall association with health remains complex given the possible protective effects of moderate alcohol consumption on some conditions. With our comprehensive approach to health accounting within the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we generated improved estimates of ...
Added: August 31, 2018
Vlassov V., JAMA Pediatrics 2017 Vol. 171 No. 6 P. 573-592
Importance Comprehensive and timely monitoring of disease burden in all age groups, including children and adolescents, is essential for improving population health.
Objective To quantify and describe levels and trends of mortality and nonfatal health outcomes among children and adolescents from 1990 to 2015 to provide a framework for policy discussion.
Evidence Review Cause-specific mortality and nonfatal ...
Added: April 6, 2017
Vlassov V., The Lancet 2017 Vol. 390 No. 10100 P. 1260-1344
Background
Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and programme decision making. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures ...
Added: September 15, 2017
Vlassov V., The Lancet 2015 Vol. 386 No. 9995 P. 743-800
Background Up-to-date evidence about levels and trends in disease and injury incidence, prevalence, and years lived with disability (YLDs) is an essential input into global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013), we estimated these quantities for acute and chronic diseases and injuries for 188 countries between ...
Added: June 7, 2015
Vlassov V., The Lancet 2016 Vol. 388 No. 10053 P. 1725-1774
Background
Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in ...
Added: October 13, 2016
Vlassov V., The Lancet 2016 Vol. 388 No. 10053 P. 1725-1774
BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases ...
Added: April 11, 2014
Vlassov V., The Lancet HIV 2016 Vol. 3 No. 8 P. e361-e387
Background
Timely assessment of HIV/AIDS burden is essential for policy-setting and program evaluation. Based on
the Global Burden of Disease study 2015 (GBD 2015), we provide national estimates of levels and trends
of HIV/AIDS incidence, prevalence, ART coverage and mortality for 195 countries and territories from
1980 to 2015.
Methods
For countries without high quality vital registration data, we estimated prevalence ...
Added: July 9, 2016
Vlassov V., Neuro-epidemiology 2015 Vol. 45 No. 3 P. 177-189
Background: There is increasing recognition of stroke as an important contributor to childhood morbidity and mortality. Current estimates of global childhood stroke burden and its temporal trends are sparse. Accurate and up-to-date estimates of childhood stroke burden are important for planning research and the resulting evidence-based strategies for stroke prevention and management. Objectives: To estimate ...
Added: October 29, 2015
GBD 2019 Adolescent Young Adult Cancer C., Otstavnov S., Vlassov V., The Lancet Oncology 2022 Vol. 23 No. 1 P. 27-52
Background: In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed ...
Added: December 13, 2021